Join the Koch Institute for Integrative Cancer Research at MIT for this free seminar.
Learn from Spectradyne's CEO Jean-Luc Fraikin about how its ARC particle analyzer is delivering new insights in LNP-loading and nanomedicine, virus and gene therapy, and extracellular vesicle applications.
January 24, 2024
11 a.m. — 12 p.m. ET
Building 76, Room 156B
